SVFCX vs. PYCR, SPT, ASAN, ACIW, QTWO, TDC, RPD, NCNO, APPN, and BL
Should you be buying Smead Value C stock or one of its competitors? The main competitors of Smead Value C include Paycor HCM (PYCR), Sprout Social (SPT), Asana (ASAN), ACI Worldwide (ACIW), Q2 (QTWO), Teradata (TDC), Rapid7 (RPD), nCino (NCNO), Appian (APPN), and BlackLine (BL). These companies are all part of the "computer and technology" sector.
Paycor HCM (NASDAQ:PYCR) and Smead Value C (NASDAQ:SVFCX) are both mid-cap computer and technology companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, earnings, analyst recommendations, community ranking, media sentiment, institutional ownership, dividends, valuation and risk.
Smead Value C has a net margin of 0.00% compared to Smead Value C's net margin of -13.82%. Smead Value C's return on equity of 1.28% beat Paycor HCM's return on equity.
In the previous week, Paycor HCM had 3 more articles in the media than Smead Value C. MarketBeat recorded 3 mentions for Paycor HCM and 0 mentions for Smead Value C. Paycor HCM's average media sentiment score of 0.00 beat Smead Value C's score of -0.31 indicating that Smead Value C is being referred to more favorably in the news media.
Paycor HCM has a beta of 0.5, meaning that its stock price is 50% less volatile than the S&P 500. Comparatively, Smead Value C has a beta of 0.11, meaning that its stock price is 89% less volatile than the S&P 500.
Smead Value C has lower revenue, but higher earnings than Paycor HCM.
Paycor HCM received 27 more outperform votes than Smead Value C when rated by MarketBeat users. However, 100.00% of users gave Smead Value C an outperform vote while only 33.72% of users gave Paycor HCM an outperform vote.
36.8% of Paycor HCM shares are held by institutional investors. Comparatively, 60.2% of Smead Value C shares are held by institutional investors. 0.4% of Paycor HCM shares are held by insiders. Comparatively, 10.3% of Smead Value C shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Paycor HCM presently has a consensus target price of $27.35, suggesting a potential upside of 57.47%. Given Smead Value C's higher probable upside, analysts plainly believe Paycor HCM is more favorable than Smead Value C.
Summary
Paycor HCM beats Smead Value C on 8 of the 14 factors compared between the two stocks.
Get Smead Value C News Delivered to You Automatically
Sign up to receive the latest news and ratings for SVFCX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SVFCX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
SVFCX vs. The Competition
Smead Value C Competitors List
Related Companies and Tools
